Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Yonsei University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- fentanyl consumption for IV-PCA
Study Overview
Brief Summary
Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Masking
- Double (Participant, Care Provider)
Eligibility Criteria
- Ages
- 1 Year to 5 Years (Child)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy
Exclusion Criteria
- •cardiovascular, renal, liver disease or growth retardation
Arms & Interventions
remifentanil 0.6 mcg/kg/min
Group 0.6 (n = 15): remifentanil 0.6 mcg/kg/min
Intervention: remifentanil (Drug)
saline
Group S (n = 15): saline
Intervention: remifentanil (Drug)
remifentanil 0.3 mcg/kg/min
Group 0.3 (n = 15): remifentanil 0.3 mcg/kg/min
Intervention: remifentanil (Drug)
remifentanil 0.9 mcg/kg/min
Group 0.9 (n = 15): remifentanil 0.9 mcg/kg/min
Intervention: remifentanil (Drug)
Outcomes
Primary Outcomes
fentanyl consumption for IV-PCA
Time Frame: 24 h and 48 h after surgery
Postoperative pain score
Time Frame: during 48 h after surgery
Secondary Outcomes
No secondary outcomes reported
Investigators
Jeong-Yeon Hong
associate professor
Yonsei University
